Publications by authors named "Henrik Hjorth-Hansen"

40Publications

Plasma proteomics of biomarkers for inflammation or cancer cannot predict relapse in chronic myeloid leukaemia patients stopping tyrosine kinase inhibitor therapy.

Leuk Res 2020 03 23;90:106310. Epub 2020 Jan 23.

Department of Medical Sciences, Uppsala University, Uppsala, Sweden; Section of Hematology, Uppsala University Hospital, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2020.106310DOI Listing
March 2020

Ponatinib in chronic myeloid leukemia (CML): Consensus on patient treatment and management from a European expert panel.

Crit Rev Oncol Hematol 2017 Dec 8;120:52-59. Epub 2017 Oct 8.

Department of Hematology and Oncology "L. and A. Seràgnoli," St Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10408428173006
Publisher Site
http://dx.doi.org/10.1016/j.critrevonc.2017.10.002DOI Listing
December 2017

Tyrosine kinase inhibitor therapy-induced changes in humoral immunity in patients with chronic myeloid leukemia.

J Cancer Res Clin Oncol 2017 Aug 23;143(8):1543-1554. Epub 2017 Mar 23.

Hematology Research Unit Helsinki, Department of Hematology, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Haartmaninkatu 8, 00290, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-017-2378-6DOI Listing
August 2017

Early BCR-ABL1 Transcript Decline after 1 Month of Tyrosine Kinase Inhibitor Therapy as an Indicator for Treatment Response in Chronic Myeloid Leukemia.

PLoS One 2017 30;12(1):e0171041. Epub 2017 Jan 30.

Hematology Research Unit Helsinki, Department of Hematology, University of Helsinki and Helsinki University Central Hospital Comprehensive Cancer Center, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0171041PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5279791PMC
August 2017

Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders.

Authors:
Asbjørg Stray-Pedersen Hanne Sørmo Sorte Pubudu Samarakoon Tomasz Gambin Ivan K Chinn Zeynep H Coban Akdemir Hans Christian Erichsen Lisa R Forbes Shen Gu Bo Yuan Shalini N Jhangiani Donna M Muzny Olaug Kristin Rødningen Ying Sheng Sarah K Nicholas Lenora M Noroski Filiz O Seeborg Carla M Davis Debra L Canter Emily M Mace Timothy J Vece Carl E Allen Harshal A Abhyankar Philip M Boone Christine R Beck Wojciech Wiszniewski Børre Fevang Pål Aukrust Geir E Tjønnfjord Tobias Gedde-Dahl Henrik Hjorth-Hansen Ingunn Dybedal Ingvild Nordøy Silje F Jørgensen Tore G Abrahamsen Torstein Øverland Anne Grete Bechensteen Vegard Skogen Liv T N Osnes Mari Ann Kulseth Trine E Prescott Cecilie F Rustad Ketil R Heimdal John W Belmont Nicholas L Rider Javier Chinen Tram N Cao Eric A Smith Maria Soledad Caldirola Liliana Bezrodnik Saul Oswaldo Lugo Reyes Francisco J Espinosa Rosales Nina Denisse Guerrero-Cursaru Luis Alberto Pedroza Cecilia M Poli Jose L Franco Claudia M Trujillo Vargas Juan Carlos Aldave Becerra Nicola Wright Thomas B Issekutz Andrew C Issekutz Jordan Abbott Jason W Caldwell Diana K Bayer Alice Y Chan Alessandro Aiuti Caterina Cancrini Eva Holmberg Christina West Magnus Burstedt Ender Karaca Gözde Yesil Hasibe Artac Yavuz Bayram Mehmed Musa Atik Mohammad K Eldomery Mohammad S Ehlayel Stephen Jolles Berit Flatø Alison A Bertuch I Celine Hanson Victor W Zhang Lee-Jun Wong Jianhong Hu Magdalena Walkiewicz Yaping Yang Christine M Eng Eric Boerwinkle Richard A Gibbs William T Shearer Robert Lyle Jordan S Orange James R Lupski

J Allergy Clin Immunol 2017 01 16;139(1):232-245. Epub 2016 Jul 16.

Baylor-Hopkins Center for Mendelian Genomics of the Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Tex; Department of Pediatrics, Baylor College of Medicine, and Texas Children's Hospital, Houston, Tex; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Tex; Human Genome Sequencing Center, Baylor College of Medicine, Houston, Tex. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaci.2016.05.042DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5222743PMC
January 2017

Assessment of bone marrow lymphocytic status during tyrosine kinase inhibitor therapy and its relation to therapy response in chronic myeloid leukaemia.

J Cancer Res Clin Oncol 2016 May 8;142(5):1041-50. Epub 2016 Jan 8.

Hematology Research Unit Helsinki, Department of Hematology, University of Helsinki and Helsinki University Central Hospital Comprehensive Cancer Center, Haartmaninkatu 8, P.O. Box 700, 00290, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-015-2101-4DOI Listing
May 2016

The tyrosine kinase inhibitors imatinib and dasatinib reduce myeloid suppressor cells and release effector lymphocyte responses.

Mol Cancer Ther 2015 May 11;14(5):1181-91. Epub 2015 Mar 11.

Department of Medical Sciences, Uppsala University, Uppsala, Sweden. Section of Hematology, Uppsala University Hospital, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://mct.aacrjournals.org/cgi/doi/10.1158/1535-7163.MCT-14
Publisher Site
http://dx.doi.org/10.1158/1535-7163.MCT-14-0849DOI Listing
May 2015

Imatinib and pegylated IFN-α2b discontinuation in first-line chronic myeloid leukemia patients following a major molecular response.

Eur J Haematol 2014 28;92(5):413-20. Epub 2014 Jan 28.

Hematology Research Unit Helsinki, Department of Medicine, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/ejh.12258
Publisher Site
http://dx.doi.org/10.1111/ejh.12258DOI Listing
December 2014

Symptomatic primary (Al) amyloidosis of the stomach and duodenum.

Case Rep Gastrointest Med 2013 25;2013:525439. Epub 2013 Feb 25.

Department of Gastroenterology and Hepatology, St. Olavs Hospital, Prinsesse Kristinas Gate 1, 7006 Trondheim, Norway ; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Prinsesse Kristinas Gate 1, 7489 Trondheim, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2013/525439DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596920PMC
March 2013

Imatinib inhibits proliferation of human mesenchymal stem cells and promotes early but not late osteoblast differentiation in vitro.

J Bone Miner Metab 2012 Jan 14;30(1):119-23. Epub 2011 Oct 14.

Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00774-011-0323-3DOI Listing
January 2012

Interferon alpha for treatment of chronic myeloid leukemia.

Curr Drug Targets 2011 Mar;12(3):420-8

Department of Hematology, University of Uppsala, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/138945011794815301DOI Listing
March 2011

Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two cases.

Acta Haematol 2009 29;122(1):11-6. Epub 2009 Jul 29.

Department of Medical Biochemistry, Stavanger University Hospital, Stavanger, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000230037DOI Listing
November 2009

Abnormal adipokine levels and leptin-induced changes in gene expression profiles in multiple myeloma.

Eur J Haematol 2009 Nov 31;83(5):460-70. Epub 2009 Jul 31.

Department of Biomaterials, Institute for Clinical Dentistry, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0609.2009.01311.xDOI Listing
November 2009

Metformin and early pregnancy?

Fertil Steril 2006 Nov 22;86(5):1551-2; author reply 1552-3. Epub 2006 Aug 22.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.fertnstert.2006.05.009DOI Listing
November 2006

Primary chronic cold agglutinin disease: a population based clinical study of 86 patients.

Haematologica 2006 Apr;91(4):460-6

Department of Medicine, Haugesund Hospital, Haugesund, Norway.

View Article

Download full-text PDF

Source
April 2006

Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma.

Haematologica 2004 Feb;89(2):174-82

Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway.

View Article

Download full-text PDF

Source
February 2004

Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells.

Oncogene 2004 Apr;23(17):3024-32

Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim N-7489, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1207386DOI Listing
April 2004

Interleukin-21 is a growth and survival factor for human myeloma cells.

Blood 2002 May;99(10):3756-62

Department of Cancer Research and Molecular Biology, Norwegian University of Science and Technology, Trondheim, Norway.

View Article

Download full-text PDF

Source
https://ashpublications.org/blood/article/99/10/3756/107004/
Publisher Site
http://dx.doi.org/10.1182/blood.v99.10.3756DOI Listing
May 2002